Loading...
Zynex, Inc.
ZYXI•NASDAQ
Healthcare
Medical - Distribution
$2.54
$-0.04(-1.74%)
Zynex, Inc. (ZYXI) Financial Performance & Income Statement Overview
Review Zynex, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
4.36%
↑ 4.36%
Operating Income Growth
-44.43%
↓ 44.43%
Net Income Growth
-69.24%
↓ 69.24%
Operating Cash Flow Growth
-28.36%
↓ 28.36%
Operating Margin
-4.43%
↓ 4.43%
Gross Margin
77.67%
↑ 77.67%
Net Profit Margin
-4.30%
↓ 4.30%
ROE
-23.70%
↓ 23.70%
ROIC
-8.53%
↓ 8.53%
Zynex, Inc. (ZYXI) Income Statement & Financial Overview
Review Zynex, Inc.'s (ZYXI) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $26.58M | $45.97M | $49.97M | $49.88M |
| Cost of Revenue | $8.37M | $9.98M | $10.18M | $9.97M |
| Gross Profit | $18.21M | $35.99M | $39.79M | $39.91M |
| Gross Profit Ratio | $0.69 | $0.78 | $0.80 | $0.80 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $31.31M | $36.55M | $35.99M | $37.69M |
| Operating Expenses | $31.31M | $36.55M | $35.99M | $37.69M |
| Total Costs & Expenses | $39.67M | $46.54M | $46.16M | $47.66M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $615000.00 | $625000.00 | $630000.00 |
| Depreciation & Amortization | $1.10M | $0.00 | $1.11M | $1.16M |
| EBITDA | -$12.001M | -$563000.00 | $4.91M | $3.38M |
| EBITDA Ratio | -$0.45 | -$0.01 | $0.10 | $0.07 |
| Operating Income | -$13.10M | -$563000.00 | $3.80M | $2.23M |
| Operating Income Ratio | -$0.49 | -$0.01 | $0.08 | $0.04 |
| Other Income/Expenses (Net) | -$703000.00 | -$615000.00 | -$625000.00 | -$611000.00 |
| Income Before Tax | -$13.80M | -$1.18M | $3.18M | $1.61M |
| Income Before Tax Ratio | -$0.52 | -$0.03 | $0.06 | $0.03 |
| Income Tax Expense | -$3.40M | -$563000.00 | $795000.00 | $398000.00 |
| Net Income | -$10.40M | -$615000.00 | $2.38M | $1.22M |
| Net Income Ratio | -$0.39 | -$0.01 | $0.05 | $0.02 |
| EPS | -$0.33 | -$0.02 | $0.07 | $0.04 |
| Diluted EPS | -$0.33 | -$0.02 | $0.07 | $0.04 |
| Weighted Avg Shares Outstanding | $31.60M | $31.94M | $31.77M | $31.76M |
| Weighted Avg Shares Outstanding (Diluted) | $31.60M | $32.30M | $32.09M | $32.20M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan